p38MAP激酶抑制剂
| 英文名 | LY2228820 | CAS号 | 862507-23-1 |
| 试剂别名 |
3H-Imidazo[4,5-b]pyridin-2-amine, 5-[2-(1,1-dimethylethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-, methanesulfonate (1:2);3H-Imidazo[4,5-b]pyridin-2-amine, 5-[2-(1,1-dimethylethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl...;3H-Imidazo[4,5-b]pyridin-2-amine, 5-[2-(1,1-dimethylethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-, meth;5-(2-tert-Butyl-5-(4-fluorophenyl)-1H-imidazol-4-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine methanesulfonate;5-[2-tert-butyl-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)imidazo[4,5-b]pyridin-2-amine,methanesulfonic acid;LY 2228820;LY2228820 (LY-2228820, LY 2228820);LY-2228820;LY2228820 2MsOH;LY2228820 dimesylate;Ralimetinib dimesylate;Ralimetinib Mesylate;UNII-QUW7B71FO9
|
分子式 | C26H37FN6O6S2 |
| 产品编号 | APEA5566 | 分子量 | 612.74 |
| MDL号 |
| 产品名称： | p38MAP激酶抑制剂 |
| 英文名称： | LY2228820 |
| 英文别名： | 3H-Imidazo[4,5-b]pyridin-2-amine, 5-[2-(1,1-dimethylethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-, methanesulfonate (1:2);3H-Imidazo[4,5-b]pyridin-2-amine, 5-[2-(1,1-dimethylethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl...;3H-Imidazo[4,5-b]pyridin-2-amine, 5-[2-(1,1-dimethylethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-, meth;5-(2-tert-Butyl-5-(4-fluorophenyl)-1H-imidazol-4-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine methanesulfonate;5-[2-tert-butyl-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)imidazo[4,5-b]pyridin-2-amine,methanesulfonic acid;LY 2228820;LY2228820 (LY-2228820, LY 2228820);LY-2228820;LY2228820 2MsOH;LY2228820 dimesylate;Ralimetinib dimesylate;Ralimetinib Mesylate;UNII-QUW7B71FO9 |
| 中文别名： | LY 2228820;LY-2228820 |
| CAS No.： | 862507-23-1 |
| 分子式： | C26H37FN6O6S2 |
| 分子量： | 612.74 |
| 危险品级别： | |
| HS符号： | |
| 危害声明： |
